AllSight
Companies · TFX · Surgical & Medical Instruments & Apparatus

TELEFLEX INC (TFX)

TELEFLEX INC (TFX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

TELEFLEX INC (TFX) stock — financials & valuation

Key numbers for TELEFLEX INC (TFX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 41/100 — a percentile rank of TELEFLEX INC’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$5.3B
P / S2.6×
EV / EBITDA21.2×
Return on equity-10.9%
Debt / equity1.0×
Dividend yield1.1%

Is TELEFLEX INC overvalued? P/S looks undervalued vs its 5-year range; EV/EBITDA looks overvalued vs its 5-year range; P/B looks undervalued vs its 5-year range.

Independent of the events above — derived from TELEFLEX INC’s own financial statements and shown as context, never as advice.

Sep 8, 2026Board expanded to nine
Teleflex adds Medtronic veteran to board, but offers no immediate financial catalyst
Aug 7, 2026
Teleflex launches the first $250 million tranche of its planned buyback
Aug 6, 2026
Integration delays cut growth outlook, but buybacks lift EPS guidance
Related companies in Surgical & Medical Instruments & Apparatus
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact